Director – Software Product Management, Enterprise AI Orchestration at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Demonstrated ability to influence C-suite stakeholders and drive organizational change
  • Excellence in strategic thinking with ability to translate vision into executable strategies

Responsibilities

  • Define and drive the enterprise AI orchestration strategy, establishing how Lilly deploys and manages AI agents at organizational scale
  • Enable measurement of Digital Worker Impact (DWI) and AI workforce ROI across the enterprise
  • Establish governance models for enterprise AI deployment that balance innovation with compliance requirements
  • Partner with C-suite and senior leaders to align AI workforce strategy with business transformation goals
  • Own the PharmAI platform roadmap (enterprise AI orchestration platform) and associated enterprise orchestration capabilities
  • Define integration strategies with existing platforms and products to create a unified AI ecosystem
  • Establish standards for agent interoperability and workflow orchestration across business units
  • Drive development of business-specific AI studios (Finance, Legal, Clinical, etc.) in partnership with domain leaders
  • Create playbooks and frameworks for business units to build and manage their AI workforces
  • Establish Centers of Excellence for AI workforce deployment across key business areas
  • Define success metrics and KPIs for enterprise AI adoption and impact
  • Build executive dashboards for AI workforce visibility and governance
  • Monitor pharmaceutical industry trends in enterprise AI adoption and workforce transformation
  • Influence enterprise-wide AI adoption strategy and change management
  • Partner with HR, Finance, and Operations on AI workforce planning and impact assessment
  • Lead cross-functional steering committees for major AI transformation initiatives
  • Serve as a spokesperson for enterprise AI orchestration internally and externally

Skills

Product Management
AI Orchestration
Generative AI
AI Agents
Workflow Management
Enterprise AI
Product Strategy
AI Platforms
Agent Monitoring
Business Impact Measurement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI